Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 33)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A MYL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: MYLAN -- MYL 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: BVF , ELN , ENDP , KG , MYL , WCRX -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of MYLAN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for MYL: the economy's impact on MYL's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
Next 20

Brokerage Reports (Showing 1 to 8 of 8)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
5-Nov-09 Collins Stewart LLC Louise Chen Quality 3Q09 Beat, Focus on Dysport Launch, Solodyn and Pipeline 13 $50 View Abstract
30-Oct-09 Thomson StreetEvents N/A MYL - Event Transcript of Mylan Inc. conference call, Oct. 29, 2009 / 10:00am ET 21 $75 View Abstract
30-Oct-09 Thomson StreetEvents N/A MYL - Event Brief of Mylan Inc. conference call, Oct. 29, 2009 / 10:00am ET 21 $75 View Abstract
29-Oct-09 Collins Stewart LLC Louise Chen Quality 3Q09 Beat, 2010 Growth Will Drive Stock Price Appreciation 13 $50 View Abstract
16-Oct-09 Collins Stewart LLC Louise Chen November 2009 Stock Catalysts 22 $75 View Abstract
15-Oct-09 Collins Stewart LLC Louise Chen Key Takeaways From IMS Review of Worldwide Pharma Market in 2010 8 $25 View Abstract
14-Oct-09 Collins Stewart LLC Louise Chen Visibility Improving For 2011 Earnings With Vfend Settlement 3 $10 View Abstract
20-Mar-09 Collins Stewart LLC Louise Chen Key Takeaways From Meeting With Strides Arcolab 3 $12 View Abstract

Independent Reports (Showing 1 to 10 of 25)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A MYL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: MYLAN -- MYL 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: BVF , ELN , ENDP , KG , MYL , WCRX -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of MYLAN INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for MYL: the economy's impact on MYL's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
Next 15

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.